Conference Agenda
Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).
|
Session Overview | |
Location: ETH E21 D-BSSE, ETH, 54 seats |
Date: Monday, 25/Aug/2025 | |
11:30am - 1:00pm |
Prediction / prognostic modelling 1 Location: ETH E21 Developing a clinical prediction model with a continuous outcome: sample size calculations to target precise predictions Sequential sample size calculations for developing clinical prediction models: learning curves suggest larger datasets are needed for individual-level stability Determining the Sample Size for Risk Prediction Models with Clustered Binary Data Conformal prediction intervals for the individual treatment effect Effective sample size for Cox survival models: A measure of individual uncertainty in predictions |
2:00pm - 3:30pm |
Joint / longitudinal modelling Location: ETH E21 Assessing surrogacy from joint modelling and mediation analysis when surrogates are either censored event times or longitudinal biomarker: cancer application Joint Modelling Using Semiparametric Accelerated Failure Time Approaches: Application to Health-Related Quality of Life Analysis Using Joint Models to Assess Delayed Initiation of Salvage Therapy following Biochemical Recurrence for Prostate Cancer. Faster Estimation of Quasi-Monte Carlo Methods for Joint Models of Multivariate Longitudinal Data and Penalized Cox Regression Regularization and Flexible Methods to Improve Complete Cancer Prevalence Predictions in the Prevalence Incidence Analysis Model |
4:00pm - 5:30pm |
Biomarker studies & diagnostic tests Location: ETH E21 Assessing diagnostic accuracy for three-class classification problems Biological Age Estimation in the Estonian Biobank Based on NMR Metabolomics Data and Phenotype Bézier curve parametric method for approximating ROC curves in the context of multiple clinical decision thresholds Deriving Cost-effective Neyman-Pearson Classifier with Multiple-Modality Detection Tools Improving Biomarker Diagnostic Accuracy with the Likelihood Ratio Transformation |
Date: Tuesday, 26/Aug/2025 | |
9:15am - 10:45am |
Design and analysis of trials in rare diseases Location: ETH E21 Blinded sample size re-estimation accounting for estimation error with small internal pilot studies Randomization in clinical trials with small sample sizes using group sequential designs Adjusting for allocation bias in stratified clinical trials with multi-component endpoints Methodological insights from the EPISTOP trial for designing and analysing clinical trials in rare diseases Modified crossover trials to improve feasibility of evaluating multiple treatments for rare relapsing-remitting conditions |
11:30am - 1:00pm |
Statistical methods in epidemiology Location: ETH E21 Federated Inference methods for estimation and comparison of Standardized Mortality Ratios A mixture model for subtype identification: Application to CADASIL Performance of a residual-based algorithm aiming at identifying response shift at the item level using Rasch models: a simulation study Lifecourse modelling and time-varying covariates: empirical application and simulation study for novel method Emulating hypothetical interventions of physical activity on obesity: applying target trial emulation in the 1970 Birth Cohort Study |
Date: Wednesday, 27/Aug/2025 | |
9:00am - 10:30am |
Biomarker studies & mixed topics Location: ETH E21 Quantifying the Clinical Usefulness of Novel Biomarkers and Tests: Beyond Traditional Statistics The underlap coefficient as measure of a biomarker’s discriminatory ability in a multi-class disease setting Time-dependent accuracy for Continuous Biomarkers using Copula Modelling Sample size determination for hypothesis testing of the intraclass correlation coefficient for agreement in two-way ANOVA models Accounting for misclassification of binary outcomes in external control arm studies for unanchored indirect comparisons: simulations and applied example |
2:00pm - 3:30pm |
Observational/real-world data 1 Location: ETH E21 Handling informative patient monitoring in routinely-collected data used to estimate treatment effects, with application to high-frequency hospital data Target Trial Emulation to Duplicate Randomized Clinical Trials using Registry Data in Multiple Sclerosis Exploring Synthetic Control Data Quality Between Data Types in Two Case Studies: COVID-19 and Crohn’s Disease The most appropriate method for outlier detection in a clinical audit depends on the data distribution Incorporating real-world data to refine the calculation of probability of success |
4:00pm - 5:30pm |
Observational/real-world data 2 Location: ETH E21 Group measurement invariance assessment with item-level latent variable models: A comparative simulation study of two methods Linkage of HIV treatment and population-based surveillance records in rural South Africa Investigating Statistical Inference for Consistency, Heterogeneity and Efficacy of Federated Learning Models: Insights from a Mega-Simulation of Real-World Data Characterizing Medication Timelines in Huntington’s Disease: A Cluster-Based Analysis of Treatment Patterns Testing the Similarity of Healthcare Pathways based on Transition Probabilities - A New Bootstrap Procedure |
Contact and Legal Notice · Contact Address: Privacy Statement · Conference: ISCB46 |
Conference Software: ConfTool Pro 2.6.154+TC © 2001–2025 by Dr. H. Weinreich, Hamburg, Germany |